IDIX – This abstract would seem to imply that the dose of NM283 ought to be raised when given with ribavirin, but this is not what IDIX and NVS are actually doing. Comments?
I wonder what other goodies will come out of ICAAC, which started today (#msg-13329051)?
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”